Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Tax Provisions (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 14 years of Tax Provisions data on record, last reported at $33000.0 in Q2 2025.

  • For Q2 2025, Tax Provisions rose 157.89% year-over-year to $33000.0; the TTM value through May 2025 reached $43000.0, down 76.5%, while the annual FY2025 figure was $43000.0, 76.5% down from the prior year.
  • Tax Provisions reached $33000.0 in Q2 2025 per LFCR's latest filing, up from -$8000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $230000.0 in Q2 2023 and bottomed at -$1.7 million in Q3 2021.
  • Average Tax Provisions over 5 years is -$247750.0, with a median of -$2000.0 recorded in 2022.
  • The widest YoY moves for Tax Provisions: up 2100.0% in 2023, down 1725.0% in 2023.
  • A 5-year view of Tax Provisions shows it stood at -$1.7 million in 2021, then surged by 100.24% to $4000.0 in 2022, then tumbled by 1725.0% to -$65000.0 in 2023, then surged by 166.15% to $43000.0 in 2024, then decreased by 23.26% to $33000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $33000.0 in Q2 2025, -$8000.0 in Q1 2025, and $43000.0 in Q4 2024.